The Cytel Blog: Perspectives on Enquiry & Evidence

When submitting systematic literature reviews to a Health Technology Assessment authority, high volumes of research..

While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..

If you are a pharmaceutical or biotech company seeking to enter the market with a new drug, you need to submit a..

At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium..

This past decade has undoubtedly witnessed an increase in the number of single arm trials submitted to HTA bodies...

The Life Sciences landscape has seen an impactful digital evolution in the past two years. The pandemic has accelerated..

A randomized clinical trial (RCT) is the gold standard approach to demonstrate the efficacy and safety of novel..

The value of Real World Evidence (RWE) is well known to many stakeholders, but its full potential for market access and..

The prominent European conference for Health Economics and Outcomes Research (HEOR), ISPOR Europe 2021, is around the..